You are here

Article Text

Article menu
Download PDFPDF
Matters arising
Treatment with etidronate for men with idiopathic osteoporosis
  1. PIET GEUSENS,
  2. JOHAN VANHOOF,
  3. JEF RAUS
  1. JAN DEQUEKER,
  2. JOS NIJS,
  3. JO JOLY
  1. Dr L Willems-Instituut, Limburgs Universitair Centrum, B-3590 Diepenbeek, Belgium
  2. Arthritis and Metabolic Bone Disease Research Unit, K U Leuven, Belgium
  1. Dr P Geusens.

https://doi.org/10.1136/ard.56.4.280a

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    In a recent overview of current and potential future drug treatments for osteoporosis, the therapies for osteoporosis in men were discussed briefly.1 Osteoporosis in men is a heterogeneous disease of which 50% of the cases are classified as idiopathic osteoporosis (IOP).2 Long term data on treatment of men with IOP are not yet available.

    In an uncontrolled open study of 22 white men with IOP, we have studied prospectively, the effect of a two year treatment with cyclic etidronate (400 mg/d during two weeks every three months) and calcium (500 mg/d during 10 weeks every three months). …

    View Full Text